TERN vs VICI · $6.12B cap vs P/E 9.3, rev $3.85B
Terns Pharmaceuticals Inc (TERN) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
TERN currently screens at market cap $6.12B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the TERN and VICI stock pages for the full models.
Not investment advice.